During the progression of IDD, the gradual loss of collagen II and aggrecan due to NP ECM metabolic disorder leads to a decrease in IVD height, loss of the boundary between the AF and NP, and a decline in the ability to withstand mechanical loads [51]. The gene discussed is ACAN; the disease is Other metabolic disease.